Japan Drops Moderna For Un-Authorized COVID-19 Vaccine | WHAT REALLY HAPPENED X-Frame-Options: SAMEORIGIN

Japan Drops Moderna For Un-Authorized COVID-19 Vaccine

Takeda Pharmaceutical Company Limited announced on September 7, 2021, the Government of Japan’s Ministry of Health, Labour, and Welfare (MHLW) will purchase 150 million doses of Novavax’s COVID-19 vaccine candidate (NVX-CoV2373, TAK-019 in Japan).

Takeda will be responsible for the Japanese clinical trial and regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency and will distribute TAK-019 in Japan if approved by the MHLW.

Takeda confirmed these COVID-19 vaccines would be manufactured in Japan by Takeda, subject to licensing and approval.

Additionally, Novavax is licensing and transferring technologies to enable Takeda to manufacture the vaccine antigen and supply the Matrix-M TM adjuvant to Takeda to fill/finish together with the antigen.

Previously, Takeda had partnered with the Government of Japan and Moderna to help accelerate the availability of COVID-19 vaccines.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA